BRPI0200827B8 - association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children - Google Patents
association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in childrenInfo
- Publication number
- BRPI0200827B8 BRPI0200827B8 BRPI0200827A BRPI0200827B8 BR PI0200827 B8 BRPI0200827 B8 BR PI0200827B8 BR PI0200827 A BRPI0200827 A BR PI0200827A BR PI0200827 B8 BRPI0200827 B8 BR PI0200827B8
- Authority
- BR
- Brazil
- Prior art keywords
- association
- children
- treatment
- silver nitrate
- intralesional
- Prior art date
Links
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 title abstract 6
- 229910001961 silver nitrate Inorganic materials 0.000 title abstract 3
- 229940126307 triamcinolone acetate Drugs 0.000 title abstract 3
- 201000011066 hemangioma Diseases 0.000 title abstract 2
- 230000008595 infiltration Effects 0.000 title abstract 2
- 238000001764 infiltration Methods 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
"associação do acetato de triancinolona 40mg com o nitrato de prata a 0,5% no tratamento dos hemangiomas e dos linfohemangiomas por infiltração intralesional em crianças". a presente invenção desta associação proporciona um sinergismo que potencializa a ação desses dois produtos e que quando injetado dentro da lesão promove uma rápida redução da massa turnoral evitando a sua proliferação impedindo com isso o seu crescimento, evoluindo para a cura. até o momento foram tratadas 82 crianças de todas as idades desde recém-nascidos até a adolescência, independente de cor, sexo. a dita associação é constituída por 1,0ml de acetato de triancinolona e 1,0ml de nitrato de prata a 0,5%, utilizando-se uma seringa descartável de 10ml e uma agulha para aspiração das substâncias, e uma agulha longa de 24mm para a injeção intralesional, todo o procedimento é realizado em ambiente estéril e hospitalar com todos os cuidados de higienização. essa invenção vem solucionar um problema sério de patologias que causam deformidades severas em que o paciente é excluído do convívio social e que até há pouco tempo era impossível o tratamento realizado, tanto do ponto de vista cirúrgico como clínico."association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children". the present invention of this association provides a synergism that enhances the action of these two products and that, when injected into the lesion, promotes a rapid reduction of the tumor mass, preventing its proliferation, thus preventing its growth, evolving towards healing. so far, 82 children of all ages from newborns to adolescence have been treated, regardless of color or sex. said association consists of 1.0ml of triamcinolone acetate and 1.0ml of 0.5% silver nitrate, using a 10ml disposable syringe and a needle for aspiration of the substances, and a 24mm long needle for the intralesional injection, the entire procedure is performed in a sterile and hospital environment with all hygienic precautions. this invention comes to solve a serious problem of pathologies that cause severe deformities in which the patient is excluded from social life and which, until recently, treatment was impossible, both surgically and clinically.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0200827-0 BRPI0200827B8 (en) | 2002-03-08 | 2002-03-08 | association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0200827-0 BRPI0200827B8 (en) | 2002-03-08 | 2002-03-08 | association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0200827A BR0200827A (en) | 2003-11-11 |
| BRPI0200827B1 BRPI0200827B1 (en) | 2017-06-20 |
| BRPI0200827B8 true BRPI0200827B8 (en) | 2021-05-25 |
Family
ID=61333334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0200827-0 BRPI0200827B8 (en) | 2002-03-08 | 2002-03-08 | association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0200827B8 (en) |
-
2002
- 2002-03-08 BR BR0200827-0 patent/BRPI0200827B8/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0200827B1 (en) | 2017-06-20 |
| BR0200827A (en) | 2003-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gealh et al. | Treatment of oral myiasis caused by Cochliomyia hominivorax: two cases treated with ivermectin | |
| Hardy | Etiology, diagnosis, and treatment of septic arthritis, osteitis, and osteomyelitis in foals | |
| Paice et al. | Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases | |
| Balcin et al. | A comparative study of two methods of surgical treatment for painful neuroma | |
| Quaba et al. | A users guide for reducing the pain of local anaesthetic administration | |
| Reis Júnior et al. | Digital block with or without the addition of epinephrine in the anesthetic solution | |
| Hickey et al. | Hair toe tourniquet syndrome in a four-year-old boy | |
| BRPI0200827B8 (en) | association of 40mg triamcinolone acetate with 0.5% silver nitrate in the treatment of hemangiomas and lymphohemangiomas by intralesional infiltration in children | |
| Kerrary et al. | Acute compartment syndrome following fibula flap harvest for mandibular reconstruction | |
| Chen et al. | Effects of patient-and operation-related factors on postoperative pain after orthognathic surgery | |
| Powers | Common procedures in psittacines | |
| Inês et al. | Soft tissue injections | |
| RU2332990C1 (en) | Method for treatment of trophic ulcers in patients with diabetes | |
| Wathen et al. | Regional anesthesia in the pediatric emergency department | |
| CA2986941C (en) | New use of isoquinoline derivatives for diabetic wound healing | |
| Martínez-Arboleda et al. | Ultrasound-guided supracondylar radial nerve block for closed reduction of a distal radius fracture in the emergency department: Case report | |
| RU2268050C1 (en) | Method for treating omphalitis in calves | |
| Flarity et al. | Wound care and laceration repair for nurse practitioners in emergency care: part I | |
| Facca | Techniques of nail anesthesia | |
| RU2380098C2 (en) | Method for prevention of postocclusive syndrome in x-ray endovascular treatment of myomas of body of uterus | |
| Huang et al. | Medical treatment of a female patient with complicated Klippel–Trenaunay syndrome | |
| Bilal | Question 1: Does use of a splint increase the functional duration of cannulae in neonates? | |
| Limb | Orthopedic Infections—Clinical Applications of | |
| RU2548512C2 (en) | Method for anaesthetic support in surgical interventions in patients with diabetic foot | |
| Kabat et al. | Effect of Slowly Absorbed Epinephrine in Experimental Shock. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI |
|
| B65X | Notification of requirement for priority examination of patent application | ||
| B65Y | Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117) | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/03/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 08/03/2022 |